Mary Lovely PhD, RN, CNRN, lives in San Francisco, United States and is a Special IBTA Advisor.
Mary also consults for Tocagen Inc. as a Patient Support and Liaison and is available to answer questions from patients or their caregivers about Tocagen’s Toca 5 virus trial for people with recurrent glioblastoma or anaplastic astrocytoma: (858) 412-8473; email@example.com.
Dr. Lovely earned her PhD at the University of California San Francisco (UCSF) School of Nursing focusing on symptom management and brain tumor patient care.
During her Post Doctoral Fellowship she studied the effects of fatigue on brain tumor patients. Mary developed a program of research around long-term effects experienced by patients and families with brain tumors. She has numerous presentations and publications as Assistant Adjunct Professor in the UCSF School of Nursing.
Mary has held positions with the American Brain Tumor Association and the National Brain Tumor Society. In these roles, she communicated with patients and families about clinical issues, nationally and internationally, and developed conferences for patients and healthcare professionals.
Dr. Lovely co-facilitates an active brain tumor support group in San Francisco, is on the Board of the Milton Marks Family Camp, and reviews prospective articles for many journals. She presently consults for patients and families dealing with cognitive issues following cancer. She is First Author for Clinical Nursing Practice Guidelines for Adult Brain Tumor Patients through the American Association of Neuroscience Nurses.